Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 135
Filtrar
1.
Nutr. hosp ; 39(4): 888-895, jul. - ago. 2022. tab
Artigo em Espanhol | IBECS | ID: ibc-212008

RESUMO

Introducción: la anemia en los niños puede provocar deficiencias cognitivas y motoras que pueden conducir a dificultades en el rendimiento académico y la resistencia física, afectando a la salud y el bienestar. Objetivo: desarrollar y validar una escala de creencias sobre la adherencia al tratamiento con suplemento de hierro en madres de niños con anemia (ECATSH) que viven en una región de altitud del Perú. Métodos: se efectuó un estudio transversal en 192 madres de niños con anemia que viven en una región de elevada altitud del Perú. Se utilizó el modelo de creencias de salud (MCS) para desarrollar y validar la ECATSH. Para la validez del contenido se utilizó el análisis de juicio de expertos (V de Aiken) y para la validez del constructo, el análisis factorial exploratorio. La confiabilidad se determinó por consistencia interna. Resultados: en la validez del contenido, la prueba V de Aiken reflejó valores concordantes para la pertinencia (0,60 a 0,90), relevancia (0,75 a 0,95), claridad (0,80 a 0,90) y la escala total (0,75 a 0,92). Los valores de la alfa de Cronbach por pregunta oscilaron desde α = 0,70 hasta 0,81, y para la escala total fue de α = 0,75. El análisis factorial exploratorio (AFE) reflejó valores de Kaiser-Meyer-Olkin (KMO) de 0,733, la prueba de esfericidad de Bartlett indicó un valor de 968,680 (p < 0,001). Los valores propios en las cinco dimensiones reflejaron valores desde 1,05 hasta 4,03. El porcentaje de la varianza para el factor 1 (beneficios = 33,58 %), factor 2 (gravedad = 12,61 %), factor 3 (señales de acción = 10,78 %), factor 4 (barreras = 8,07 %), factor 5 (susceptibilidad = 7,63 %) y total de la escala fue de 74,12 %. Conclusión: el MCS es una herramienta útil que permitió validar la escala de creencias sobre la adherencia al tratamiento con suplemento de hierro en madres de niños con anemia que viven a elevada altitud del Perú (AU)


Introduction: anemia in children can cause cognitive and motor deficits that can lead to difficulties in academic performance, physical endurance, affecting health and well-being Objective: to develop and validate a scale of beliefs about adherence to iron supplementation treatment in mothers of children with anemia (SBAIST) living in a high altitude region of Peru. Methods: a cross-sectional study was conducted in 192 mothers of children with anemia living in a high altitude region of Peru. The Health Belief Model (HBM) was used to develop and validate the SBAIST. Expert judgment analysis (Aiken's V) was used for content validity and exploratory factor analysis for construct validity. Reliability was determined by internal consistency. Results: for content validity, Aiken's V test showed concordant values for relevance (0.60 to 0.90), relevance (0.75 to 0.95), clarity (0.80 to 0.90) and total scale (0.75 to 0.92). Cronbach's alpha values per question ranged from 〈 = 0.70 to 0.81, and for total scale was 〈 = 0.75. The exploratory factor analysis (EFA) reflected Kaiser-Meyer-Olkin (KMO) values of 0.733, Bartlett's test of sphericity indicated a value of 968.680 (p < 0.001). The eigenvalues in the five dimensions reflected values from 1.05 to 4.03. The percentage of variance for factor 1 (barriers = 33.58 %), factor 2 (severity = 12.61 %), factor 3 (action cues = 10.78 %), factor 4 (barriers = 8.07 %), factor 5 (susceptibility = 7.63 %), and for the total scale was 74.12 %. Conclusion: HBM is a useful tool that allowed validation of the scale of beliefs about adherence to iron supplementation treatment in mothers of children with anemia living at high altitude in Peru (AU)


Assuntos
Humanos , Feminino , Lactente , Pré-Escolar , Adulto Jovem , Adulto , Conhecimentos, Atitudes e Prática em Saúde , Cooperação e Adesão ao Tratamento , Suplementos Nutricionais , Anemia/dietoterapia , Ferro da Dieta/administração & dosagem , Mães , Índice de Gravidade de Doença , Reprodutibilidade dos Testes , Inquéritos e Questionários , Estudos Transversais
2.
J Sci Food Agric ; 102(3): 1114-1123, 2022 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-34329496

RESUMO

BACKGROUND: Iron deficiency and iron overload can affect the normal functioning of the innate and adaptive immune responses. Fermented milk products may enhance immune functions, but little is known about the effect of fermented milks on modulation of the immune response during iron deficiency anemia and recovery with normal or high dietary iron intake. Eighty male Wistar rats were randomly assigned to a control group fed a standard diet or to an anemic group fed a diet deficit in iron. Control and anemic groups were fed for 30 days with diets based on a fermented goat's or cow's milk product, with normal iron content or iron overload. RESULTS: In general, during anemia recovery lectin and alternative complement pathway activity and lactoferrin decreased, because it improves iron homeostasis, which is critically important in immune system functions. Fermented goat's milk diet enhanced immune function during iron deficiency recovery, suppressed oxidant-induced eotaxin and fractalkine expression due to the concurrent reduction of free radical production and pro-inflammatory cytokines, and decreased monocyte chemoattractant protein-1 and monocyte migration and adhesion. The increase in interferon-γ can confer immunological colonization of gut microbiota and downregulate inflammation. CONCLUSION: Fermented goat's milk consumption enhances immune function, modifying complement pathway activity and decreasing pro-inflammatory cytokines as well as lactoferrin concentration, due to the improvement of iron homeostasis, which is critically important in the normal function of the immune system. © 2021 The Authors. Journal of The Science of Food and Agriculture published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.


Assuntos
Anemia/dietoterapia , Produtos Fermentados do Leite/análise , Deficiências de Ferro/dietoterapia , Deficiências de Ferro/imunologia , Anemia/imunologia , Anemia/metabolismo , Animais , Bovinos , Feminino , Cabras , Humanos , Imunidade , Ferro/metabolismo , Deficiências de Ferro/metabolismo , Masculino , Ratos , Ratos Wistar
3.
Gac Sanit ; 35 Suppl 2: S271-S274, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34929829

RESUMO

OBJECTIVE: The purpose of this review is to describe an intervention that utilizes dates as a source of nutrition for pregnant women to increase hemoglobin levels in the blood in anemia incidence. The findings in this study are related to the use of dates to increase hemoglobin levels in the blood in pregnant women. METHODS: This study uses search databases used in PubMed, Science Direct, and Google Scholar. The keywords used in the initial search for articles are dates and hemoglobin obtained as many as 189 articles. At the time of using the keywords dates, hemoglobin, anemia by obtaining 15 articles and which are used only 10 articles according to the analysis of the purpose, suitability of the topic, the method of research used, sample size, research ethics, the results of each article, as well as limitations that occur. RESULT: Anemia in pregnant women causes hemoglobin (Hb) levels to decrease in the blood; the capacity of oxygen transfer to meet the needs of vital organs in the mother and fetus is reduced. All literature reviewed shows that administration of dates increases hemoglobin levels; only one literature shows no influence of consumes date juice on hemoglobin level. The majority of the literature reviewed is mild anemia. CONCLUSION: There are effective results in the implementation of health promotion of increased hemoglobin levels in the blood in pregnant women by utilizing dates as a source of nutrition.


Assuntos
Anemia , Frutas , Phoeniceae , Complicações Hematológicas na Gravidez/dietoterapia , Anemia/dietoterapia , Feminino , Hemoglobinas/análise , Humanos , Estado Nutricional , Gravidez
4.
Molecules ; 26(20)2021 Oct 17.
Artigo em Inglês | MEDLINE | ID: mdl-34684862

RESUMO

Iron fortifications are used for the treatment of iron-deficiency anemia; however, iron dosing may cause oxidative damage to the gut lumen. Thai Sinlek rice is abundant in iron and contains phytochemicals. We aimed at evaluating the effect of an iron-rice (IR) hydrolysate drink (100 mL/serving) on neurological function, red cell indices and iron status in elders. Healthy elderly subjects were divided into three non-anemic groups and one anemic group. The non-anemic groups consumed one WR (2 mg iron/serving) and two IR drinks (15 and 27 mg iron/serving) (groups A, B and D, respectively), while the anemic group consumed one IR drink (15 mg iron serving) (group C) every day for 30 days. There were no significant differences in the MMSE Thai 2002 and PHQ9 test scores for members of all groups, while the nutrition scores and body weight values of group D subjects were significantly increased. Hemoglobin (Hb) and mean corpuscular hemoglobin concentrations increased significantly only in group C. Serum iron and transferrin saturation levels tended to increase in group A, while these levels were decreased in members of group C. Serum antioxidant activity levels were increased in all groups, and were highest in group C. Thus, consumption of an IR drink for 15 days functioned to increase Hb and antioxidant capacity levels in anemic elders.


Assuntos
Anemia/dietoterapia , Índices de Eritrócitos , Compostos de Ferro/uso terapêutico , Oryza , Idoso , Idoso de 80 Anos ou mais , Anemia/sangue , Antioxidantes , Bebidas , Encéfalo , Feminino , Hematopoese , Humanos , Ferro/sangue , Masculino , Valor Nutritivo , Oryza/química , Tailândia
5.
Multimedia | Recursos Multimídia | ID: multimedia-9219

RESUMO

Recomendaciones nutricionales para la prevención de la anemia


Assuntos
Anemia/dietoterapia , Anemia/prevenção & controle
6.
Pak J Biol Sci ; 24(3): 366-373, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-34486322

RESUMO

<b>Background and Objective:</b> Vitamin A Deficiency (VAD) is a critical public health problem that affects the health of kids worldwide and may induce anemia and oxidative stress. The current study aimed to pre-clinically assess the effect of a cupcake, prepared to be served for primary school children, on vitamin A deficiency and related anemia and oxidative stress in rats. <b>Materials and Methods:</b> Flour of flash orange sweet potatoes, as a rich source of pro-vitamin A, was used to prepare the cupcake. The chemical composition, amino acids and sensory evaluation of the cupcake were done. The biological evaluation was carried out using 18 weaning rats in three groups (control group, vitamin A-deficient group and vitamin A-deficient group fed on a diet fortified with 20% of the prepared cupcake for two months). <b>Results:</b> The results indicated the high value of vitamin A in the prepared cupcake. Excellent sensory characteristics were noticed. Feeding on the VDA diet fortified with the prepared cupcake suppressed the reduction in Retinol-Binding Protein (RBP), hemoglobin and iron. Total Iron Binding Capacity (TIBC) increased in the VAD group. Also, feeding on the prepared cupcake suppressed the reduction in Superoxide Dismutase (SOD) and Glutathione Peroxidase (GPx) and the elevation of Malondialdehyde (MDA). <b>Conclusion:</b> It can be suggested that the prepared cupcake is promising in preventing of vitamin A deficiency and related anemia and oxidative stress. Thus, the prepared cupcake may be efficient for children to prevent vitamin A deficiency.


Assuntos
Anemia/dietoterapia , Estresse Oxidativo/fisiologia , Deficiência de Vitamina A/dietoterapia , Vitamina A/administração & dosagem , Análise de Variância , Anemia/fisiopatologia , Animais , Suplementos Nutricionais/normas , Suplementos Nutricionais/estatística & dados numéricos , Modelos Animais de Doenças , Hemoglobinas/análise , Estresse Oxidativo/efeitos dos fármacos , Ratos , Ratos Wistar , Vitamina A/uso terapêutico , Deficiência de Vitamina A/fisiopatologia
7.
Mol Cell Biochem ; 476(11): 4167-4175, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-34327604

RESUMO

The aim of our study was to investigate the effects of one-month consumption of polyphenol-rich standardized Aronia melanocarpa extract (SAE) on redox status in anemic hemodialysis patients. The study included 30 patients (Hb < 110 g/l, hemodialysis or hemodiafiltration > 3 months; > 3 times week). Patients were treated with commercially available SAE in a dose of 30 ml/day, for 30 days. After finishing the treatment blood samples were taken to evaluate the effects of SAE on redox status. Several parameters of anemia and inflammation were also followed. After the completion of the treatment, the levels of superoxide anion radical and nitrites significantly dropped, while the antioxidant capacity improved via elevation of catalase and reduced glutathione. Proven antioxidant effect was followed by beneficial effects on anemia parameters (increased hemoglobin and haptoglobin concentration, decreased ferritin and lactate dehydrogenase concentration), but SAE consumption didn't improve inflammatory status, except for minor decrease in C-reactive protein. The consumption of SAE regulates redox status (reduce the productions of pro-oxidative molecules and increase antioxidant defense) and has beneficial effects on anemia parameters. SAE could be considered as supportive therapy in patients receiving hemodialysis which are prone to oxidative stress caused by both chronic kidney disease and hemodialysis procedure. Additionally, it could potentially be a good choice for supplementation of anemic hemodialysis patients. TRN: NCT04208451 December 23, 2019 "retrospectively registered".


Assuntos
Anemia/dietoterapia , Inflamação/dietoterapia , Photinia/química , Extratos Vegetais/administração & dosagem , Polifenóis/administração & dosagem , Diálise Renal/métodos , Anemia/metabolismo , Anemia/patologia , Antioxidantes/administração & dosagem , Feminino , Humanos , Inflamação/metabolismo , Masculino , Pessoa de Meia-Idade , Oxirredução , Resultado do Tratamento
8.
Am J Clin Nutr ; 114(4): 1261-1266, 2021 10 04.
Artigo em Inglês | MEDLINE | ID: mdl-34320172

RESUMO

When public health programs with single nutrients are perceived to have a poor impact on the target health outcome, the policy response can be to supply more, by layering additional mandatory programs upon the extant programs. However, we argue for extreme caution, because nutrients (like medicines) are beneficial in the right dose, but potentially harmful when ingested in excess. Unnecessary motivations for the reactionary layering of multiple intervention programs emerge from incorrect measurements of the risk of nutrient inadequacy in the population, or incorrect biomarker cutoffs to evaluate the extent of nutrient deficiencies. The financial and social costs of additional layered programs are not trivial when traded off with other vital programs in a resource-poor economy, and when public health ethical dilemmas of autonomy, equity, and stigma are not addressed. An example of this conundrum in India is the perception of stagnancy in the response of the prevalence of anemia to the ongoing pharmacological iron supplementation program. The reaction has been a policy proposal to further increase iron intake through mandatory iron fortification of the rice provided in supplementary feeding programs like the Integrated Child Development Services and the School Mid-Day Meal. This is in addition to the ongoing pharmacological iron supplementation as well as other voluntary iron fortifications, such as those of salt and manufactured food products. However, before supplying more, it is vital to consider why the existing program is apparently not working, along with consideration of the potential for excess intake and related harms. This is relevant globally, particularly for countries contemplating multiple interventions to address micronutrient deficiencies. Supplying more by layering multiple nutrient interventions, instead of doing it right, without thoughtful considerations of social, biological, and ethics frameworks could be counterproductive. The cure, then, might well become the malady.


Assuntos
Anemia/dietoterapia , Deficiências Nutricionais/dietoterapia , Alimentos Fortificados , Ferro/administração & dosagem , Programas Obrigatórios , Política Nutricional , Saúde Pública , Anemia Ferropriva , Criança , Suplementos Nutricionais , Abastecimento de Alimentos , Humanos , Índia , Lactente , Ferro/uso terapêutico , Deficiências de Ferro , Micronutrientes , Estado Nutricional , Oryza , Oligoelementos
9.
J Nutr ; 151(Suppl 1): 15S-28S, 2021 02 15.
Artigo em Inglês | MEDLINE | ID: mdl-33582785

RESUMO

BACKGROUND: Anemia, iron deficiency, and iodine deficiency are problems of important public health concern in many parts of the world, with consequences for the health, development, and work capacity of populations. Several countries are beginning to implement double fortified salt (DFS) programs to simultaneously address iodine and iron deficiencies. OBJECTIVE: Our objective was to summarize the evidence for efficacy and effectiveness of DFS on the full range of status and functional outcomes and across different implementation and evaluation designs essential to successful interventions. METHODS: We conducted a systematic review and meta-analysis of published and gray literature examining the effects of DFS on nutritional status, cognition, work productivity, development, and morbidity of all population groups. We searched for articles in Medline, Embase, CINAHL, Cochrane Central Register, and ProQuest for randomized trials, quasi-randomized trials, and program effectiveness evaluations. RESULTS: A total of 22 studies (N individuals = 52,758) were included. Efficacy studies indicated a significant overall positive effect on hemoglobin concentration [standardized mean difference (95% CI): 0.33 (0.18, 0.48)], ferritin [0.42 (0.08, 0.76)], anemia [risk ratio (95% CI): 0.80 (0.70, 0.92)], and iron deficiency anemia [0.36 (0.24, 0.55)]. Effects on urinary iodine concentration were not significantly different between DFS and iodized salt. The impact on functional outcomes was mixed. Only 2 effectiveness studies were identified. They reported programmatic challenges including low coverage, suboptimal DFS quality, and storage constraints. CONCLUSIONS: Given the biological benefits of DFS across several populations in efficacy research, additional evaluations of robust DFS programs delivered at scale, which consider effective implementation and measure appropriate biomarkers, are needed.


Assuntos
Anemia Ferropriva/dietoterapia , Anemia/dietoterapia , Alimentos Fortificados , Iodo/uso terapêutico , Ferro da Dieta/administração & dosagem , Ferro da Dieta/uso terapêutico , Cloreto de Sódio na Dieta/uso terapêutico , Cognição , Eficiência , Estudos de Avaliação como Assunto , Nível de Saúde , Humanos , Iodo/deficiência , Deficiências de Ferro , Morbidade , Estado Nutricional
10.
Nutrients ; 13(1)2021 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-33467587

RESUMO

Children with inflammatory bowel disease (IBD) are at risk of developing nutrition deficiencies, particularly because of reduced intake, restrictive diets, malabsorption, and excessive nutrient loss. The aim of this study was to determine the prevalence and predictors of anemia and micronutrient deficiencies at diagnosis and one year follow up in children and adolescents with inflammatory bowel disease (IBD). Children and young adults diagnosed with IBD before the age of 17 years between 2012 and 2018 were included. Laboratory measurements including serum levels of iron, ferritin, zinc, vitamin D, vitamin A, vitamin E, selenium, copper, vitamin B12, and red blood cell (RBC) folate at diagnosis and one-year follow-up were documented as part of the Manitoba Longitudinal Pediatric Inflammatory Bowel Disease (MALPID) Cohort. A total of 165 patients with IBD were included, 87 (53%) with Crohn's disease (CD) and 78 (47%) with ulcerative colitis (UC). The prevalence of deficiencies in our cohort at diagnosis and one year follow-up, respectively, were iron (56% and 27%), ferritin (39% and 27%), zinc (10% and 6%), vitamin D (22% and 13%), vitamin A (25% and 25%), vitamin E (5% and 4%), selenium (10 and 7%), copper (17% and 27%), vitamin B12 (2% and 5%), and Red blood cell (RBC) folate (1% and 17%). Anemia was present in 57% and 25% at diagnosis and follow up respectively. In CD patients, age of diagnosis (15y-younger than 18y) was a predictor of moderate to severe anemia and albumin levels (<33 g/L) were protective against anemia. Many children with IBD suffer from anemia and micronutrient deficiencies at diagnosis and some fail to recover after one year despite being in clinical remission.


Assuntos
Anemia/diagnóstico , Anemia/etiologia , Deficiências Nutricionais/diagnóstico , Deficiências Nutricionais/etiologia , Doenças Inflamatórias Intestinais/complicações , Micronutrientes/deficiência , Adolescente , Fatores Etários , Anemia/dietoterapia , Biomarcadores , Criança , Deficiências Nutricionais/dietoterapia , Suplementos Nutricionais , Suscetibilidade a Doenças , Feminino , Seguimentos , Humanos , Doenças Inflamatórias Intestinais/diagnóstico , Masculino , Índice de Gravidade de Doença
11.
Cochrane Database Syst Rev ; 1: CD011302, 2021 01 18.
Artigo em Inglês | MEDLINE | ID: mdl-33461239

RESUMO

BACKGROUND: Anaemia is a condition where the number of red blood cells (and consequently their oxygen-carrying capacity) is insufficient to meet the body's physiological needs. Fortification of wheat flour is deemed a useful strategy to reduce anaemia in populations. OBJECTIVES: To determine the benefits and harms of wheat flour fortification with iron alone or with other vitamins and minerals on anaemia, iron status and health-related outcomes in populations over two years of age. SEARCH METHODS: We searched CENTRAL, MEDLINE, Embase, CINAHL, 21 other databases and two trials registers up to 21 July 2020, together with contacting key organisations to identify additional studies. SELECTION CRITERIA: We included cluster- or individually-randomised controlled trials (RCTs) carried out among the general population from any country, aged two years and above. The interventions were fortification of wheat flour with iron alone or in combination with other micronutrients. We included trials comparing any type of food item prepared from flour fortified with iron of any variety of wheat DATA COLLECTION AND ANALYSIS: Two review authors independently screened the search results and assessed the eligibility of studies for inclusion, extracted data from included studies and assessed risks of bias. We followed Cochrane methods in this review. MAIN RESULTS: Our search identified 3538 records, after removing duplicates. We included 10 trials, involving 3319 participants, carried out in Bangladesh, Brazil, India, Kuwait, Philippines, South Africa and Sri Lanka. We identified two ongoing studies and one study is awaiting classification. The duration of interventions varied from 3 to 24 months. One study was carried out among adult women and one trial among both children and nonpregnant women. Most of the included trials were assessed as low or unclear risk of bias for key elements of selection, performance or reporting bias. Three trials used 41 mg to 60 mg iron/kg flour, three trials used less than 40 mg iron/kg and three trials used more than 60 mg iron/kg flour. One trial used various iron levels based on type of iron used: 80 mg/kg for electrolytic and reduced iron and 40 mg/kg for ferrous fumarate. All included studies contributed data for the meta-analyses. Iron-fortified wheat flour with or without other micronutrients added versus wheat flour (no added iron) with the same other micronutrients added Iron-fortified wheat flour with or without other micronutrients added versus wheat flour (no added iron) with the same other micronutrients added may reduce by 27% the risk of anaemia in populations (risk ratio (RR) 0.73, 95% confidence interval (CI) 0.55 to 0.97; 5 studies, 2315 participants; low-certainty evidence). It is uncertain whether iron-fortified wheat flour with or without other micronutrients reduces iron deficiency (RR 0.46, 95% CI 0.20 to 1.04; 3 studies, 748 participants; very low-certainty evidence) or increases haemoglobin concentrations (in g/L) (mean difference MD 2.75, 95% CI 0.71 to 4.80; 8 studies, 2831 participants; very low-certainty evidence). No trials reported data on adverse effects in children (including constipation, nausea, vomiting, heartburn or diarrhoea), except for risk of infection or inflammation at the individual level. The intervention probably makes little or no difference to the risk of Infection or inflammation at individual level as measured by C-reactive protein (CRP) (mean difference (MD) 0.04, 95% CI -0.02 to 0.11; 2 studies, 558 participants; moderate-certainty evidence). Iron-fortified wheat flour with other micronutrients added versus unfortified wheat flour (nil micronutrients added) It is unclear whether wheat flour fortified with iron, in combination with other micronutrients decreases anaemia (RR 0.77, 95% CI 0.41 to 1.46; 2 studies, 317 participants; very low-certainty evidence). The intervention probably reduces the risk of iron deficiency (RR 0.73, 95% CI 0.54 to 0.99; 3 studies, 382 participants; moderate-certainty evidence) and it is unclear whether it increases average haemoglobin concentrations (MD 2.53, 95% CI -0.39 to 5.45; 4 studies, 532 participants; very low-certainty evidence). No trials reported data on adverse effects in children. Nine out of 10 trials reported sources of funding, with most having multiple sources. Funding source does not appear to have distorted the results in any of the assessed trials. AUTHORS' CONCLUSIONS: Fortification of wheat flour with iron (in comparison to unfortified flour, or where both groups received the same other micronutrients) may reduce anaemia in the general population above two years of age, but its effects on other outcomes are uncertain. Iron-fortified wheat flour in combination with other micronutrients, in comparison with unfortified flour, probably reduces iron deficiency, but its effects on other outcomes are uncertain. None of the included trials reported data on adverse side effects except for risk of infection or inflammation at the individual level. The effects of this intervention on other health outcomes are unclear. Future studies at low risk of bias should aim to measure all important outcomes, and to further investigate which variants of fortification, including the role of other micronutrients as well as types of iron fortification, are more effective, and for whom.


Assuntos
Anemia/dietoterapia , Farinha , Alimentos Fortificados , Ferro/administração & dosagem , Triticum , Adolescente , Adulto , Anemia/sangue , Criança , Pré-Escolar , Ácido Edético/administração & dosagem , Feminino , Compostos Férricos/administração & dosagem , Compostos Ferrosos/administração & dosagem , Fumaratos , Hemoglobina A/análise , Humanos , Lactente , Deficiências de Ferro , Masculino , Micronutrientes/administração & dosagem , Pessoa de Meia-Idade , Ensaios Clínicos Controlados Aleatórios como Assunto , Adulto Jovem
12.
Gac. sanit. (Barc., Ed. impr.) ; 35(supl. 2): S271-S274, 2021. ilus, tab
Artigo em Inglês | IBECS | ID: ibc-220957

RESUMO

Objective: The purpose of this review is to describe an intervention that utilizes dates as a source of nutrition for pregnant women to increase hemoglobin levels in the blood in anemia incidence. The findings in this study are related to the use of dates to increase hemoglobin levels in the blood in pregnant women. Methods: This study uses search databases used in PubMed, Science Direct, and Google Scholar. The keywords used in the initial search for articles are dates and hemoglobin obtained as many as 189 articles. At the time of using the keywords dates, hemoglobin, anemia by obtaining 15 articles and which are used only 10 articles according to the analysis of the purpose, suitability of the topic, the method of research used, sample size, research ethics, the results of each article, as well as limitations that occur. Result: Anemia in pregnant women causes hemoglobin (Hb) levels to decrease in the blood; the capacity of oxygen transfer to meet the needs of vital organs in the mother and fetus is reduced. All literature reviewed shows that administration of dates increases hemoglobin levels; only one literature shows no influence of consumes date juice on hemoglobin level. The majority of the literature reviewed is mild anemia. Conclusion: There are effective results in the implementation of health promotion of increased hemoglobin levels in the blood in pregnant women by utilizing dates as a source of nutrition. (AU)


Assuntos
Humanos , Anemia/dietoterapia , Frutas , Complicações Hematológicas na Gravidez/dietoterapia , Phoeniceae , Estado Nutricional , Hemoglobinas/análise
13.
Nutr. clín. diet. hosp ; 41(1): 123-129, 2021. tab
Artigo em Inglês | IBECS | ID: ibc-202479

RESUMO

OBJECTIVE: The aim of the present study was to evaluate potential predictive factors for the aggravation of COVID-19 in patients hospitalized at a reference hospital in northeastern Brazil. METHODS: A non-paired case-control study was conducted with 235 patients hospitalized at a reference hospital in northeastern Brazil between March and April 2020.The case group was composed of individuals who required hospitalization in the ICU. The control group was composed of patients hospitalized due to COVID-19 who did not meet the criteria established in the institutional protocol for classification as "severe case of the disease" and therefore did not require intensive care. RESULTS: The case group was composed of 84 patients with a median age of 45 years (P25-P75: 36-59); 63.1% weremen; 56.0% were less than 60 years of age; 76.2% had excess weight; 14.3% had a previous heart disease; 46.4% had hypertension; 11.9% had lung disease; and 67.1% took continuous-use medications. The median stay of severe cases in the ICU was positively correlated with weight and BMI only among female patients less than 60 years of age. CONCLUSION: The logistic regression analysis revealed that age older than 60 years and a compromised cardiovascular system were independent predictive factors for the severity of COVID-19


OBJECTIVE: The aim of the present study was to evaluate potential predictive factors for the aggravation of COVID-19 in patients hospitalized at a reference hospital in northeastern Brazil. METHODS: A non-paired case-control study was conducted with 235 patients hospitalized at a reference hospital in northeastern Brazil between March and April 2020. The case group was composed of individuals who required hospitalization in the ICU. The control group was composed of patients hospitalized due to COVID-19 who did not meet the criteria established in the institutional protocol for classification as "severe case of the disease" and therefore did not require intensive care. RESULTS: The case group was composed of 84 patients with a median age of 45 years (P25-P75: 36-59); 63.1% were men; 56.0% were less than 60 years of age; 76.2% had excess weight; 14.3% had a previous heart disease; 46.4% had hypertension; 11.9% had lung disease; and 67.1% took continuous-use medications. The median stay of severe cases in the ICU was positively correlated with weight and BMI only among female patients less than 60 years of age. CONCLUSION: The logistic regression analysis revealed that age older than 60 years and a compromised cardiovascular system were independent predictive factors for the severity of COVID-19


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Infecções por Coronavirus/epidemiologia , Unidades de Terapia Intensiva/estatística & dados numéricos , Hospitalização , Valor Preditivo dos Testes , Doenças Cardiovasculares/complicações , Estudos de Casos e Controles , Pandemias , Índice de Massa Corporal , Brasil , Modelos Logísticos , Índice de Gravidade de Doença , Fatores de Risco , Obesidade/complicações , Hipertensão/complicações , Anemia/dietoterapia
14.
Cochrane Database Syst Rev ; 7: CD011302, 2020 07 17.
Artigo em Inglês | MEDLINE | ID: mdl-32677706

RESUMO

BACKGROUND: Anaemia is a condition where the number of red blood cells (and consequently their oxygen-carrying capacity) is insufficient to meet the body's physiologic needs. Fortification of wheat flour is deemed a useful strategy to reduce anaemia in populations. OBJECTIVES: To determine the benefits and harms of wheat flour fortification with iron alone or with other vitamins and minerals on anaemia, iron status and health-related outcomes in populations over two years of age. SEARCH METHODS: We searched CENTRAL, MEDLINE, Embase, CINAHL, and other databases up to 4 September 2019. SELECTION CRITERIA: We included cluster- or individually randomised controlled trials (RCT) carried out among the general population from any country aged two years and above. The interventions were fortification of wheat flour with iron alone or in combination with other micronutrients. Trials comparing any type of food item prepared from flour fortified with iron of any variety of wheat were included. DATA COLLECTION AND ANALYSIS: Two review authors independently screened the search results and assessed the eligibility of studies for inclusion, extracted data from included studies and assessed risk of bias. We followed Cochrane methods in this review. MAIN RESULTS: Our search identified 3048 records, after removing duplicates. We included nine trials, involving 3166 participants, carried out in Bangladesh, Brazil, India, Kuwait, Phillipines, Sri Lanka and South Africa. The duration of interventions varied from 3 to 24 months. One study was carried out among adult women and one trial among both children and nonpregnant women. Most of the included trials were assessed as low or unclear risk of bias for key elements of selection, performance or reporting bias. Three trials used 41 mg to 60 mg iron/kg flour, two trials used less than 40 mg iron/kg and three trials used more than 60 mg iron/kg flour. One trial employed various iron levels based on type of iron used: 80 mg/kg for electrolytic and reduced iron and 40 mg/kg for ferrous fumarate. All included studies contributed data for the meta-analyses. Seven studies compared wheat flour fortified with iron alone versus unfortified wheat flour, three studies compared wheat flour fortified with iron in combination with other micronutrients versus unfortified wheat flour and two studies compared wheat flour fortified with iron in combination with other micronutrients versus fortified wheat flour with the same micronutrients (but not iron). No studies included a 'no intervention' comparison arm. None of the included trials reported any other adverse side effects (including constipation, nausea, vomiting, heartburn or diarrhoea). Wheat flour fortified with iron alone versus unfortified wheat flour (no micronutrients added) Wheat flour fortification with iron alone may have little or no effect on anaemia (risk ratio (RR) 0.81, 95% confidence interval (CI) 0.61 to 1.07; 5 studies; 2200 participants; low-certainty evidence). It probably makes little or no difference on iron deficiency (RR 0.43, 95% CI 0.17 to 1.07; 3 studies; 633 participants; moderate-certainty evidence) and we are uncertain about whether wheat flour fortified with iron increases haemoglobin concentrations by an average 3.30 (g/L) (95% CI 0.86 to 5.74; 7 studies; 2355 participants; very low-certainty evidence). No trials reported data on adverse effects in children, except for risk of infection or inflammation at the individual level. The intervention probably makes little or no difference to risk of Infection or inflammation at individual level as measured by C-reactive protein (CRP) (moderate-certainty evidence). Wheat flour fortified with iron in combination with other micronutrients versus unfortified wheat flour (no micronutrients added) Wheat flour fortified with iron, in combination with other micronutrients, may or may not decrease anaemia (RR 0.95, 95% CI 0.69 to 1.31; 2 studies; 322 participants; low-certainty evidence). It makes little or no difference to average risk of iron deficiency (RR 0.74, 95% CI 0.54 to 1.00; 3 studies; 387 participants; moderate-certainty evidence) and may or may not increase average haemoglobin concentrations (mean difference (MD) 3.29, 95% CI -0.78 to 7.36; 3 studies; 384 participants; low-certainty evidence). No trials reported data on adverse effects in children. Wheat flour fortified with iron in combination with other micronutrients versus fortified wheat flour with same micronutrients (but not iron) Given the very low certainty of the evidence, the review authors are uncertain about the effects of wheat flour fortified with iron in combination with other micronutrients versus fortified wheat flour with same micronutrients (but not iron) in reducing anaemia (RR 0.24, 95% CI 0.08 to 0.71; 1 study; 127 participants; very low-certainty evidence) and in reducing iron deficiency (RR 0.42, 95% CI 0.18 to 0.97; 1 study; 127 participants; very low-certainty evidence). The intervention may make little or no difference to the average haemoglobin concentration (MD 0.81, 95% CI -1.28 to 2.89; 2 studies; 488 participants; low-certainty evidence). No trials reported data on the adverse effects in children. Eight out of nine trials reported source of funding with most having multiple sources. Funding source does not appear to have distorted the results in any of the assessed trials. AUTHORS' CONCLUSIONS: Eating food items containing wheat flour fortified with iron alone may have little or no effect on anaemia and probably makes little or no difference in iron deficiency. We are uncertain on whether the intervention with wheat flour fortified with iron increases haemoglobin concentrations improve blood haemoglobin concentrations. Consuming food items prepared from wheat flour fortified with iron, in combination with other micronutrients, has little or no effect on anaemia, makes little or no difference to iron deficiency and may or may not improve haemoglobin concentrations. In comparison to fortified flour with micronutrients but no iron, wheat flour fortified with iron with other micronutrients, the effects on anaemia and iron deficiency are uncertain as certainty of the evidence has been assessed as very low. The intervention may make little or no difference to the average haemoglobin concentrations in the population. None of the included trials reported any other adverse side effects. The effects of this intervention on other health outcomes are unclear.


Assuntos
Anemia/dietoterapia , Farinha , Alimentos Fortificados , Ferro/administração & dosagem , Triticum , Adolescente , Adulto , Anemia/sangue , Criança , Pré-Escolar , Ácido Edético/administração & dosagem , Feminino , Compostos Férricos/administração & dosagem , Compostos Ferrosos/administração & dosagem , Fumaratos , Hemoglobina A/análise , Humanos , Lactente , Deficiências de Ferro , Masculino , Micronutrientes/administração & dosagem , Pessoa de Meia-Idade , Ensaios Clínicos Controlados Aleatórios como Assunto , Adulto Jovem
15.
BMJ ; 370: m2397, 2020 07 22.
Artigo em Inglês | MEDLINE | ID: mdl-32699176

RESUMO

OBJECTIVE: To assess the effects of food supplementation on improving working memory and additional measures including cerebral blood flow in children at risk of undernutrition. DESIGN: Randomized controlled trial. SETTING: 10 villages in Guinea-Bissau. PARTICIPANTS: 1059 children aged 15 months to 7 years; children younger than 4 were the primary population. INTERVENTIONS: Supervised isocaloric servings (≈1300 kJ, five mornings each week, 23 weeks) of a new food supplement (NEWSUP, high in plant polyphenols and omega 3 fatty acids, within a wide variety and high fortification of micronutrients, and a high protein content), or a fortified blended food (FBF) used in nutrition programs, or a control meal (traditional rice breakfast). MAIN OUTCOME MEASUREMENTS: The primary outcome was working memory, a core executive function predicting long term academic achievement. Additional outcomes were hemoglobin concentration, growth, body composition, and index of cerebral blood flow (CBFi). In addition to an intention-to-treat analysis, a predefined per protocol analysis was conducted in children who consumed at least 75% of the supplement (820/925, 89%). The primary outcome was assessed by a multivariable Poisson model; other outcomes were assessed by multivariable linear mixed models. RESULTS: Among children younger than 4, randomization to NEWSUP increased working memory compared with the control meal (rate ratio 1.20, 95% confidence interval 1.02 to 1.41, P=0.03), with a larger effect in the per protocol population (1.25, 1.06 to 1.47, P=0.009). NEWSUP also increased hemoglobin concentration among children with anemia (adjusted mean difference 0.65 g/dL, 95% confidence interval 0.23 to 1.07, P=0.003) compared with the control meal, decreased body mass index z score gain (-0.23, -0.43 to -0.02, P=0.03), and increased lean tissue accretion (2.98 cm2, 0.04 to 5.92, P=0.046) with less fat (-5.82 cm2, -11.28 to -0.36, P=0.04) compared with FBF. Additionally, NEWSUP increased CBFi compared with the control meal and FBF in both age groups combined (1.14 mm2/s×10-8, 0.10 to 2.23, P=0.04 for both comparisons). Among children aged 4 and older, NEWSUP had no significant effect on working memory or anemia, but increased lean tissue compared with FBF (4.31 cm2, 0.34 to 8.28, P=0.03). CONCLUSIONS: Childhood undernutrition is associated with long term impairment in cognition. Contrary to current understanding, supplementary feeding for 23 weeks could improve executive function, brain health, and nutritional status in vulnerable young children living in low income countries. Further research is needed to optimize nutritional prescriptions for regenerative improvements in cognitive function, and to test effectiveness in other vulnerable groups. TRIAL REGISTRATION: ClinicalTrials.gov NCT03017209.


Assuntos
Anemia/dietoterapia , Disfunção Cognitiva/dietoterapia , Suplementos Nutricionais/efeitos adversos , Desnutrição/dietoterapia , Estado Nutricional/fisiologia , Sucesso Acadêmico , Anemia/epidemiologia , Estudos de Casos e Controles , Circulação Cerebrovascular/fisiologia , Criança , Pré-Escolar , Cognição/fisiologia , Disfunção Cognitiva/fisiopatologia , Suplementos Nutricionais/estatística & dados numéricos , Feminino , Alimentos Fortificados/provisão & distribuição , Guiné-Bissau/epidemiologia , Humanos , Lactente , Análise de Intenção de Tratamento/métodos , Masculino , Desnutrição/epidemiologia , Desnutrição/prevenção & controle , Micronutrientes/provisão & distribuição , Medição de Risco
18.
Gut Microbes ; 11(4): 820-841, 2020 07 03.
Artigo em Inglês | MEDLINE | ID: mdl-31955643

RESUMO

Infection with Helicobacter pylori causes chronic inflammation and is a risk factor for gastric cancer. Antibiotic treatment or increased dietary folate prevents gastric carcinogenesis in male INS-GAS mice. To determine potential synergistic effects, H. pylori-infected male INS-GAS mice were fed an amino acid defined (AAD) diet with increased folate and were treated with antibiotics after 18 weeks of H. pylori infection. Antibiotic therapy decreased gastric pathology, but dietary folate had no effect. However, the combination of antibiotics and the AAD diet induced anemia, gastric hemorrhage, and mortality. Clinical presentation suggested hypovitaminosis K potentially caused by dietary deficiency and dysbiosis. Based on current dietary guidelines, the AAD diet was deficient in vitamin K. Phylloquinone administered subcutaneously and via a reformulated diet led to clinical improvement with no subsequent mortalities and increased hepatic vitamin K levels. We characterized the microbiome and menaquinone profiles of antibiotic-treated and antibiotic-free mice. Antibiotic treatment decreased the abundance of menaquinone producers within orders Bacteroidales and Verrucomicrobiales. PICRUSt predicted decreases in canonical menaquinone biosynthesis genes, menA and menD. Reduction of menA from Akkermansia muciniphila, Bacteroides uniformis, and Muribaculum intestinale were confirmed in antibiotic-treated mice. The fecal menaquinone profile of antibiotic-treated mice had reduced MK5 and MK6 and increased MK7 and MK11 compared to antibiotic-free mice. Loss of menaquinone-producing microbes due to antibiotics altered the enteric production of vitamin K. This study highlights the role of diet and the microbiome in maintaining vitamin K homeostasis.


Assuntos
Antibacterianos/uso terapêutico , Disbiose/etiologia , Alimentos Formulados/efeitos adversos , Hemorragia Gastrointestinal/etiologia , Microbioma Gastrointestinal , Infecções por Helicobacter/tratamento farmacológico , Deficiência de Vitamina K/etiologia , Aminoácidos/administração & dosagem , Anemia/dietoterapia , Anemia/etiologia , Animais , Antibacterianos/efeitos adversos , Bactérias/efeitos dos fármacos , Bactérias/genética , Bactérias/metabolismo , Dieta , Suplementos Nutricionais , Ácido Fólico/administração & dosagem , Ácido Fólico/biossíntese , Ácido Fólico/genética , Microbioma Gastrointestinal/efeitos dos fármacos , Infecções por Helicobacter/microbiologia , Helicobacter pylori/efeitos dos fármacos , Fígado/metabolismo , Masculino , Camundongos , Vitamina K 1/administração & dosagem , Vitamina K 1/metabolismo , Vitamina K 2/metabolismo
19.
Vox Sang ; 115(3): 182-191, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-31877577

RESUMO

BACKGROUND AND OBJECTIVES: Preoperative anaemia is an independent risk factor for a higher morbidity and mortality, a longer hospitalization and increased perioperative transfusion rates. Managing preoperative anaemia is the first of three pillars of Patient Blood Management (PBM), a multidisciplinary concept to improve patient safety. While various studies provide medical information on (successful) anaemia treatment pathways, knowledge of organizational details of diagnosis and management of preoperative anaemia across Europe is scarce. MATERIALS AND METHODS: To gain information on various aspects of preoperative anaemia management including organization, financing, diagnostics and treatment, we conducted a survey (74 questions) in ten hospitals from seven European nations within the PaBloE (Patient Blood Management in Europe) working group covering the year 2016. RESULTS: Organization and activity in the field of preoperative anaemia management were heterogeneous in the participating hospitals. Almost all hospitals had pathways for managing preoperative anaemia in place, however, only two nations had national guidelines. In six of the ten participating hospitals, preoperative anaemia management was organized by anaesthetists. Diagnostics and treatment focused on iron deficiency anaemia which, in most hospitals, was corrected with intravenous iron. CONCLUSION: Implementation and approaches of preoperative anaemia management vary across Europe with a primary focus on treating iron deficiency anaemia. Findings of this survey motivated the hospitals involved to critically evaluate their practice and may also help other hospitals interested in PBM to develop action plans for diagnosis and management of preoperative anaemia.


Assuntos
Anemia/terapia , Gerenciamento Clínico , Ferro/administração & dosagem , Cuidados Pré-Operatórios , Anemia/dietoterapia , Anemia Ferropriva/dietoterapia , Anemia Ferropriva/terapia , Transfusão de Sangue , Europa (Continente) , Feminino , Hospitais , Humanos , Masculino
20.
Clin. biomed. res ; 40(1): 21-26, 2020.
Artigo em Português | LILACS | ID: biblio-1116646

RESUMO

Introdução: Evidências têm mostrado uma associação entre anemia e Diabetes Mellitus. Contudo, a relação entre anemia e Diabetes Mellitus Gestacional (DMG) ainda não está bem estabelecida, bem como sua repercussão na instabilidade genômica. Portanto, objetivou-se verificar a associação entre anemia e instabilidade genômica em mulheres com DMG atendidas em um hospital universitário. Métodos: Estudo transversal com mulheres apresentando diagnóstico de DMG que realizaram pré-natal no Hospital Universitário de Santa Maria (RS). Informações referentes ao DMG, anemia e suplementação de ferro foram obtidas nos prontuários. A instabilidade genômica foi avaliada pelo ensaio de citoma em micronúcleos em células bucais (BMCyt). Resultados: Das 44 gestantes avaliadas, 28,6% apresentaram anemia e 79,5% foram suplementadas com ferro. Das gestantes que realizaram suplementação, 75,0% não apresentaram anemia gestacional. Níveis de hemoglobina não se associaram com a instabilidade genomica (p > 0,05), mas foi observada uma associação entre brotos nucleares e os níveis de glicemia (r = 0,977; p = 0,003). Conclusão: Não foi verificado associação entre anemia e instabilidade genômica em mulheres com DMG.(AU)


Introduction: There is evidence of an association between anemia and diabetes mellitus. However, the relationship between anemia and gestational diabetes mellitus (GDM) remains to be established, as well as its impact on genomic instability. Therefore, we aimed to examine the association between anemia and genomic instability in women with GDM treated at a university hospital. Methods: A cross-sectional study of women with a diagnosis of GDM who received prenatal care at the University Hospital of Santa Maria, southern Brazil. Data on GDM, anemia, and iron supplementation were obtained from medical records. Genomic instability was assessed by the buccal micronucleus cytome (BMCyt) assay. Results: Of 44 pregnant women evaluated, 28.6% had anemia and 79.5% received iron supplementation; of the latter, 75.0% did not have gestational anemia. Hemoglobin levels were not associated with genomic instability (p > 0.05), but an association was found between nuclear buds and blood glucose levels (r = 0.977; p = 0.003). Conclusion: There was no association between anemia and genomic instability in women with GDM.(AU)


Assuntos
Humanos , Feminino , Gravidez , Adulto , Adulto Jovem , Diabetes Gestacional/genética , Instabilidade Genômica , Anemia/genética , Cuidado Pré-Natal , Glicemia/análise , Dano ao DNA , Hemoglobinas/análise , Estudos Transversais , Anemia Ferropriva/complicações , Anemia Ferropriva/dietoterapia , Anemia Ferropriva/genética , Ferro da Dieta/uso terapêutico , Anemia/complicações , Anemia/dietoterapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...